Overview

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of azilsartan, once daily (QD), in subjects with essential hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Azilsartan medoxomil
Olmesartan
Olmesartan Medoxomil